← Back to patent-cliff list
CAS 51727-15-2
4-chloropicolinoyl chloride hydrochloride
Codes: SORF-002
Application context (from source-drug indications)
Thyroid cancerSorafenib TosylateHepatocellular carcinomaSorafenib TosylateRenal cell carcinomaSorafenib TosylateAggressive fibromatosisSorafenib TosylateLiver cancerSorafenib TosylateMyeloproliferative neoplasmSorafenib Tosylate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Sorafenib Tosylate | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
picolinic acid→4-chloropicolinoyl chloride hydrochloride→4-chloropicolinoyl chloride→4-aminophenol→4-(4-aminophenoxy)-N-methylpicolinamide→1-chloro-4-isocyanato-2-(trifluoromethyl)benzene→4-chloro-3-(trifluoromethyl)aniline
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.